🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
09/05/2000 0,0854 USD
16/02/2000 0,0854 USD
09/11/1999 0,0759 USD
04/08/1999 0,0759 USD
05/05/1999 0,0696 USD
10/02/1999 0,0696 USD
04/11/1998 0,0601 USD
05/08/1998 0,0601 USD
06/05/1998 0,0601 USD
04/02/1998 0,0601 USD
05/11/1997 0,0538 USD
30/07/1997 0,0538 USD
07/05/1997 0,0538 USD
05/02/1997 0,0538 USD
06/11/1996 0,0474 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/09/1995 7,59 7,59 7,49 7,55 -0,52% 1,30% 5.021.888
06/09/1995 7,59 7,65 7,55 7,59 +0,26% 1,30% 13.430.279
05/09/1995 7,59 7,63 7,53 7,57 -0,26% 1,30% 6.073.570
01/09/1995 7,57 7,67 7,55 7,59 -2,79% 1,57% 11.571.655
31/08/1995 7,85 7,93 7,73 7,81 -0,75% 2,52% 4.972.561
30/08/1995 7,71 7,87 7,69 7,87 +2,58% 2,31% 5.871.202
29/08/1995 7,63 7,67 7,49 7,67 +1,04% 2,33% 5.274.216
28/08/1995 7,69 7,69 7,55 7,59 -0,78% 1,80% 4.596.916
25/08/1995 7,73 7,79 7,61 7,65 -1,02% 2,30% 3.991.709
24/08/1995 7,71 7,79 7,67 7,73 +0,00% 1,54% 5.811.124
23/08/1995 7,65 7,77 7,65 7,73 +1,56% 1,55% 3.643.256
22/08/1995 7,77 7,77 7,61 7,61 -1,79% 2,04% 5.501.248
21/08/1995 7,69 7,75 7,67 7,75 +1,82% 1,03% 4.103.644
18/08/1995 7,61 7,65 7,55 7,61 +0,00% 1,30% 8.250.290
17/08/1995 7,65 7,69 7,55 7,61 +0,00% 1,81% 6.905.176
16/08/1995 7,79 7,79 7,53 7,61 -3,27% 3,30% 14.266.312
15/08/1995 7,91 7,95 7,77 7,87 -1,49% 2,25% 4.912.483
14/08/1995 7,77 7,99 7,71 7,99 +3,06% 3,56% 6.078.629
11/08/1995 7,91 7,93 7,65 7,75 -2,24% 3,50% 13.119.138
10/08/1995 7,95 8,01 7,87 7,93 +0,00% 1,74% 5.327.338
09/08/1995 7,87 8,08 7,85 7,93 +1,52% 3,02% 9.743.387
08/08/1995 7,87 7,91 7,79 7,81 -0,50% 1,51% 5.678.320
07/08/1995 7,91 7,99 7,85 7,85 -0,25% 1,75% 4.664.582
04/08/1995 7,89 7,95 7,81 7,87 +0,00% 1,75% 6.643.994
03/08/1995 7,91 7,97 7,79 7,87 -1,49% 2,25% 9.444.262
02/08/1995 8,06 8,10 7,97 7,99 -1,70% 1,71% 13.684.504
01/08/1995 7,97 8,16 7,97 8,12 +1,48% 2,48% 11.140.991
31/07/1995 7,89 8,12 7,87 8,01 +2,27% 3,26% 12.391.878
28/07/1995 7,79 7,89 7,77 7,83 +1,02% 1,52% 10.345.432
27/07/1995 7,55 7,77 7,53 7,75 +3,70% 3,14% 9.359.520